Literature DB >> 25601213

Chronic nicotine administration does not alter cognitive or mood associated behavioural parameters.

Omamuyovwi Meashack Ijomone1, Olayemi Kafilat Olaibi2, Christian Mba3, Ifechukwude Joachim Biose3, Samuel Anthony Tete3, Polycarp Umunna Nwoha2.   

Abstract

Nicotine, the major specific alkaloid in tobacco smoke, exhibits widespread pharmacological effects and may contribute to deterioration in behaviour. The present study thus examined the effects of its chronic administration on some cognitive and mood associated behaviours. Adult rats weighing between 150 and 200g were randomly divided into 4 groups each of 5 females and 5 males. Three groups were administered graded doses of nicotine at 0.25, 2 and 4mg/kg body weight via subcutaneous injections. One group served as control and received normal saline (vehicle for nicotine). Behavioural tests were performed using the Y-maze, elevated-plus maze (EPM) and tail suspension tests (TST) at various time points. Nicotine produced no significant effect in spontaneous alternation on Y-maze, nor on six parameters scored on EPM (open arm entries, time spent in open arms, time per open arm entries, open/closed arm quotient, closed arm entries, and total arm entries), and also no significant effect on immobility time in TST. This lack of effects was observed to be independent of sex and dose administered. The study shows that nicotine does not produce long-term changes in some cognitive and mood associated behaviours, thus suggesting it could be well tolerated even following chronic administration.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Behaviour; Cognition; Depression; Nicotine

Year:  2015        PMID: 25601213     DOI: 10.1016/j.pathophys.2014.12.004

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  4 in total

Review 1.  Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective.

Authors:  Morgane Besson; Benoît Forget
Journal:  Front Psychiatry       Date:  2016-09-21       Impact factor: 4.157

2.  Selenium nanoparticles and metformin ameliorate streptozotocin-instigated brain oxidative-inflammatory stress and neurobehavioral alterations in rats.

Authors:  Azubuike P Ebokaiwe; Stephen Okori; Joseph O Nwankwo; Chukwunonso E C C Ejike; Sharon O Osawe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-16       Impact factor: 3.000

3.  Parecoxib prevents early postoperative cognitive dysfunction in elderly patients undergoing total knee arthroplasty: A double-blind, randomized clinical consort study.

Authors:  Yang-Zi Zhu; Rui Yao; Zhe Zhang; Hui Xu; Li-Wei Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

4.  Effects of Dextromethorphan on Depressive-and Cognitive-Associated Behaviors: A Sexually Dimorphic Study.

Authors:  Omamuyovwi Meashack Ijomone; Ifechukwude Joachim Biose
Journal:  Basic Clin Neurosci       Date:  2019-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.